These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 2931846)

  • 61. [Chrysotherapy and side effects (author's transl)].
    Eberl R
    Wien Klin Wochenschr Suppl; 1974; 25():3-22. PubMed ID: 4279096
    [No Abstract]   [Full Text] [Related]  

  • 62. Prevalence of eosinophilia during gold therapy for rheumatoid arthritis.
    Edelman J; Davis P; Owen ET
    J Rheumatol; 1983 Feb; 10(1):121-3. PubMed ID: 6405032
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [The effect of aurotherapy on the content of corticotropin, cortisol, aldosterone and insulin in the blood serum of rheumatoid arthritis patients].
    Ornat SIa
    Vrach Delo; 1991 Jan; (1):61-5. PubMed ID: 1672783
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Gold vs D-penicillamine double blind study and followup.
    Thomas MH; Rothermich NO; Philips VK; Bergen W; Hedrick SW
    J Rheumatol; 1984 Dec; 11(6):764-7. PubMed ID: 6240537
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A randomized controlled trial of parenteral methotrexate compared with sodium aurothiomalate (Myochrysine) in the treatment of rheumatoid arthritis.
    Suarez-Almazor ME; Fitzgerald A; Grace M; Russell AS
    J Rheumatol; 1988; 15(5):753-6. PubMed ID: 3139877
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The influence of chrysotherapy on serum protein and immunoglobulin levels, rheumatoid factor, and antiepithelial antibody titers.
    Gottlieb NL; Kiem IM; Penneys NS; Schultz DR
    J Lab Clin Med; 1975 Dec; 86(6):962-72. PubMed ID: 811742
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Gold treatment of rheumatoid arthritis].
    Wagner H; Wirth W
    Z Rheumatol; 1978; 37(1-2):4-11. PubMed ID: 415451
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [A comparative evaluation of the efficacy and tolerance of gold and D-penicillamine preparations in patients with rheumatoid arthritis. II. The effect on the morphological indices of rheumatoid synovitis].
    Shekhter AB; Slobodina GA; Krel' AA; Kanevskaia MZ; Chichasova NV
    Revmatologiia (Mosk); 1990; (2):23-9; discussion 29-30. PubMed ID: 1977194
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Interleukin-2 receptor levels in sera of patients with rheumatoid arthritis treated with sulfasalazine, parenteral gold, or placebo.
    Merkel PA; Dooley MA; Dawson DV; Pisetsky DS; Polisson RP
    J Rheumatol; 1996 Nov; 23(11):1856-61. PubMed ID: 8923356
    [TBL] [Abstract][Full Text] [Related]  

  • 70. One-year comparative study of gold sodium thiomalate and auranofin in the treatment of rheumatoid arthritis.
    Davis P; Menard H; Thompson J; Harth M; Beaudet F
    J Rheumatol; 1985 Feb; 12(1):60-7. PubMed ID: 3920393
    [TBL] [Abstract][Full Text] [Related]  

  • 71. "Chorée fibrillaire de Morvan" followed by Guillain-Barré syndrome in a patient receiving gold therapy.
    Vernay D; Dubost JJ; Thevenet JP; Sauvezie B; Rampon S
    Arthritis Rheum; 1986 Nov; 29(11):1413-4. PubMed ID: 3778549
    [No Abstract]   [Full Text] [Related]  

  • 72. Efficacy and toxicity of retreatment with gold salts: a retrospective review of 25 cases.
    Sagransky DM; Greenwald RA
    J Rheumatol; 1980; 7(4):474-8. PubMed ID: 6775078
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Elevated antigalactosyl antibody titers reflect renal injury after gold or D-penicillamine in rheumatoid arthritis.
    Malaise MG; Davin JC; Mahieu PR; Franchimont P
    Clin Immunol Immunopathol; 1986 Aug; 40(2):356-64. PubMed ID: 2941196
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Liver toxicity profile in gold-treated Egyptian rheumatoid arthritis patients.
    Koryem HK; Taha KM; Ibrahim IK; Younes LK
    Int J Clin Pharmacol Res; 1998; 18(1):31-7. PubMed ID: 9604732
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Can gold therapy be used more safely in rheumatoid arthritis? Adverse drug reactions are more likely in patients with nodular disease, independent of HLA-DR3 status.
    Shah P; Griffith SM; Shadforth MF; Fisher J; Dawes PT; Poulton KV; Thomson W; Ollier WE; Mattey DL
    J Rheumatol; 2004 Oct; 31(10):1903-5. PubMed ID: 15468351
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Gold therapy in chronic polyarthritis. Differentiation of allergic and toxic side effects].
    Bene E; Megyeri A; Györi J
    Z Rheumatol; 1980; 39(3-4):109-16. PubMed ID: 6448525
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Gold therapy in rheumatoid arthritis.
    Schorn D; Anderson IF
    S Afr Med J; 1975 Aug; 49(37):1505-6. PubMed ID: 125934
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Trace elements and acute phase reactants in gold treated rheumatoid arthritis patients.
    Menard HA; Barrette M; Lamoureux G; Lecomte R; Paradis P; Monaro S; Drapeau G
    J Rheumatol Suppl; 1979; 5():143-8. PubMed ID: 114644
    [TBL] [Abstract][Full Text] [Related]  

  • 79. IV N-acetylcysteine treatment of hematologic reactions to chrysotherapy.
    Godfrey NF; Peter A; Simon TM; Lorber A
    J Rheumatol; 1982; 9(4):519-26. PubMed ID: 6813467
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Goldsalts, levamisole and D-penicillamine as first choice slow-acting antirheumatic drugs in rheumatoid arthritis--a long-term follow-up study.
    Veys EM; Mielants H; Verbruggen G
    Clin Exp Rheumatol; 1987; 5(2):111-6. PubMed ID: 3608266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.